|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.79 USD | -0.94% |
|
+0.18% | +23.14% |
| Jan. 13 | BridgeBio Pharma in Strong Cash Position to Launch Attruby | DJ |
| Jan. 13 | BridgeBio Pharma, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 07:30 AM |
Health-care companies rose, but not by as much as the broad market, amid cyclical bias.
BridgeBio Pharma rallied after the biotech firm received Food and Drug Administration approval for a rival to Pfizer's blockbuster heart drug.
Shares of Cassava Sciences plunged after a formerly promising Alzheimer's drug candidate performed poorly in a late-stage clinical trial.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
11-25-24 1725ET
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 33.79USD | -0.94% | +0.18% | 6.39B | ||
| 26.30USD | -0.72% | -1.87% | 149B | ||
| 2.750USD | +2.23% | +0.73% | 132M | ||
